See Hims & Hers Health's analyst price targets ($31) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$27.82
15 analysts in the last 4 months
High: $42 | Low: $23
No recommendations in the last 4 months.
Hims & Hers Health posts a target price of $31. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $31 for HIMS means covering analysts, on average, see the stock 12.3% upside of $27.82 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for HIMS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Hims & Hers Health's other metric pages and overview cover the third.
Judging Hims & Hers Health against Consumer Staples peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Staples are more comparable, which makes gaps in target price easier to interpret. Start with $31 here, then scan peer and history charts to see if the gap is persistent.